Loading clinical trials...
Loading clinical trials...
To determine a relatively safe contrast media volume to creatinine clearance cut-off value to avoid contrast-induced nephropathy in patients following coronary angiography
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Guangdong Provincial People's Hospital
NCT04982419 · Acute Kidney Injury, Heart Failure, and more
NCT02516072 · Remote Ischaemic Preconditioning, Contrast Induced Nephropathy
NCT01999517 · Contrast Induced Nephropathy
NCT01402232 · Contrast Induced Nephropathy
NCT02106234 · Contrast Induced Nephropathy, Acute Kidney Injury
Guangdong Cardiovascular Institute,Guangdong General Hospital
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions